3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Lymphoma, Follicular
3
Lymphoma
3
Lymphoma, Non-Hodgkin
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Kidney Neoplasms
1
Influenza, Human
1
Epstein-Barr Virus Infections
1
Breast Neoplasms
1
Blast Crisis
1
Interventions
Cyclophosphamide
10
pembrolizumab
9
Therapeutics
8
Flow Cytometry
6
Radiotherapy
5
Gemcitabine
5
Blood Specimen Collection
5
Surveys and Questionnaires
4
Sirolimus
4
Psychiatric Rehabilitation
4
Peripheral Blood Stem Cell Transplantation
4
Paclitaxel
4
Nivolumab
4
Methods
4
Ipilimumab
4
Filgrastim
4
Exercise
4
Drug Therapy
4
Doxorubicin
4
Capecitabine
4
copanlisib
3
aldesleukin
3
Rituximab
3
Polymerase Chain Reaction
3
Immunologic Techniques
3
Immunoglobulin G
3
Immunoenzyme Techniques
3
Fluorodeoxyglucose F18
3
Early Intervention, Educational
3
Disulfides
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Interferons
×
Lymphoid
×
Clear all
NCT00276536
2015-10-14
IFNa
The Cleveland Clinic
Phase 1
Completed
35 enrolled